16:06 EST Compass Therapeutics (CMPX) files $400M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMPX:
- Promising Clinical Data and Market Positioning Drive Buy Rating for Compass Therapeutics
- Canaccord starts Compass Therapeutics with a Buy ahead of tovecimig readout
- Compass Therapeutics initiated with an Overweight at Cantor Fitzgerald
- Compass Therapeutics initiated with a Buy at Canaccord
- Compass Therapeutics initiated with an Outperform at Citizens JMP